Showing results (21-30 of 210) with videos related to

Sort By:
Pageof 21
Clinical and Translational Science|October 19, 2022
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidenceJonathon C Arnold, Danielle McCartney, Anastasia Suraev, et al.
Drug and Alcohol Dependence Reports|September 15, 2025
Factors associated with cannabis use disorder among Australians using prescribed and illicitly-sourced medical cannabisLlewellyn Mills, Jonathon C Arnold, Iain S Mcgregor, et al.
Journal of Cannabis Research|October 28, 2025
Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in AustraliaNicholas Lintzeris, Jonathon C Arnold, Iain S McGregor, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 14, 2016
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophreniaDavid J Clarke, Jordyn Stuart, Iain S McGregor, et al.
Pharmacological Reports : PR|July 21, 2012
CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cellsJonathon C Arnold, Phoebe Hone, Michelle L Holland, et al.
Drug and Alcohol Review|February 16, 2022
Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical conditionLlewellyn Mills, Nicholas Lintzeris, Michael O'Malley, et al.
The AAPS Journal|June 28, 2021
Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum CharacterizationPeter T Doohan, Lachlan D Oldfield, Jonathon C Arnold, et al.
Pageof 21